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Abstract: Fungi associated with the marine sponge Tethya aurantium were isolated and 
identified  by  morphological  criteria  and  phylogenetic  analyses  based  on  internal 
transcribed  spacer  (ITS)  regions.  They  were  evaluated  with  regard  to  their  secondary 
metabolite  profiles.  Among  the  81  isolates  which  were  characterized,  members  of 
21 genera  were  identified.  Some  genera  like  Acremonium,  Aspergillus,  Fusarium, 
Penicillium,  Phoma,  and  Trichoderma  are  quite  common,  but  we  also  isolated  strains 
belonging  to  genera  like  Botryosphaeria,  Epicoccum,  Parasphaeosphaeria,  and 
Tritirachium which have rarely been  reported from sponges. Members affiliated to the 
genera Bartalinia and Volutella as well as to a presumably new Phoma species were first 
isolated  from  a  sponge  in  this  study.  On  the  basis  of  their  classification,  strains  were 
selected for analysis of their ability to produce natural products. In addition to a number of 
known compounds, several new natural products were identified. The scopularides and 
sorbifuranones have been described elsewhere. We have isolated four additional substances 
which have not been described so far. The new metabolite cillifuranone (1) was isolated 
from  Penicillium  chrysogenum  strain  LF066.  The  structure  of  cillifuranone  (1)  was 
elucidated based on 1D and 2D NMR analysis and turned out to be a previously postulated 
intermediate  in  sorbifuranone  biosynthesis.  Only  minor  antibiotic  bioactivities  of  this 
compound were found so far. 
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1. Introduction 
Natural products are of considerable importance in the discovery of new therapeutic agents [1]. 
Apart from plants, bacteria and fungi are the most important producers of such compounds [2]. For a 
long time neglected as a group of producers of natural products, marine microorganisms have more 
recently  been  isolated  from  a  variety  of  marine  habitats  such  as  sea  water,  sediments,  algae  and 
different animals to discover new natural products [3,4]. In particular, sponges which are filter feeders 
and accumulate high numbers of microorganisms have attracted attention [5,6]. Though the focus of 
most  of  these  investigations  was  concerned  with  the  bacteria,  a  series  of  investigations  identified 
marine sponges also as a good source of fungi [7–18]. Due to the accumulation of microorganisms, it 
is no surprise that sponges account for the majority of fungal species isolated from the marine realm [19]. 
However,  the  type  of  association  and  a  presumable  ecological  function  of  accumulated  fungi  in 
sponges remain unclear and little evidence is available on fungi specifically adapted to live within 
sponges. One example is represented by fungi of the genus Koralionastes, which are known to form 
fruiting bodies only in close association with crustaceous sponges associated with corals [20]. 
Consistently,  fungi  isolated  from  sponges  account  for  the  highest  number  (28%)  of  novel 
compounds reported from marine isolates of fungi [19]. Marine isolates of fungi evidently are a rich 
source  of  chemically  diverse  natural  products  which  has  not  been  consequently  exploited  so  far. 
Among a number of metabolites from sponge-associated fungi with promising biological activities are 
the cytotoxic gymnastatins and the p56
lck tyrosine kinase inhibitor ulocladol [21,11]. In view of these 
exciting  data  and  our  own  previous  work  on  the  bacterial  community  associated  with  
Tethya aurantium [22], we have now isolated and identified a larger number of fungi from this sponge. 
In European waters, Tethya aurantium is commonly found in the Atlantic Ocean, the English Channel, 
the North Sea as well as the Mediterranean Sea, where our specimens originated from [23]. Except for 
a single report from Indriani [24], fungi associated with Tethya sp. have not been investigated so far. 
The formation of natural products by these fungi and their biotechnological potential has not been 
evaluated yet.  
For the identification of the fungal isolates from Tethya aurantium, we combined morphological 
criteria  and  phylogenetic  analyses  based  on  the  sequence  of  the  internal  transcribed  spacer  (ITS) 
regions 1 and 2. On the basis of their classification, strains were selected for analysis of their ability to 
produce natural products. In addition to a number of known compounds, the new cyclodepsipeptides 
scopularide A and B were produced by a Scopulariopsis brevicaulis isolate [25]. Because of their 
antiproliferative activities against several tumor cell lines, these peptides and their activities have been 
patented [26]. During the present study, we have isolated four so far undescribed substances. Structure 
and properties of the new cillifuranone, a secondary metabolite from Penicillium chrysogenum strain 
LF066 are reported here. Mar. Drugs 2011, 9  
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2. Results and Discussion 
2.1. Identification of the Fungal Strains Isolated from T. aurantium 
In most studies on fungi associated with sponges the taxonomic classification of the fungi was 
based exclusively on morphological characteristics and in many cases identification was possible only 
at the genus level [17]. This can be attributed to the fact that taxonomic identification of fungi at the 
species level is not always easy. It is impaired by the fact that under laboratory conditions many fungi 
do not express reproductive features like conidia or ascomata, which represent important traits for 
identification. These fungi are classified as “mycelia sterilia”.  
Therefore,  morphological  criteria  as  well  as  sequence  information  and  the  determination  
of  phylogenetic  relationships  are  considered  to  be  necessary  for  the  identification  of  fungi.  
Consequently, we have combined the morphological characterization with a PCR-based analysis using  
ITS1-5.8S-rRNA-ITS2 gene sequences to identify 81 fungi isolated from Tethya aurantium. Based on 
these criteria the strains could be identified to the species level (Figure 1, Table 1).  
Figure 1. Scanning electron micrographs of Fusarium sp. strain LF236. (A) Multicellular, 
curved conidiospore; (B) Exudates in the surface layer of a liquid culture; (C) Intercalary 
chlamydospores in the mycelium. 
     
(A)        (B)        (C) 
Table 1. Identification of fungal strains isolated from Tethya aurantium samples based on 
morphological criteria as well as genetic analysis of the internal transcribed spacer (ITS) 
region. Closest relatives to fungal strains according to BLAST search are presented. In case 
BLAST search yielded a cultured but undesignated strain as closest relative, the closest 
cultured and the designated relative is given additionally. 
Strain 
Morphological 
identification 
Seq. length 
(nt) 
Next related cultivated strain (BLAST)  Acc. No. 
Similarity  
(%) 
Overlap 
(nt) 
LF063 Cladosporium sp. 483 
Fungal sp. ARIZ AZ0920 
Cladosporium sphaerospermum isolate KH00280 
HM123596.1  
GU017501.1 
99 
99 
482 
482 
LF064 
Scopulariopsis 
murina 
473 
Ascomycota sp. 840  
Phialemonium obovatum strain CBS 279.76 
GU934604.1 
AB278187.1 
92 
89 
360 
340 
LF065 Penicillium sp.  546  Penicillium glabrum strain 4AC2K  GU372904.1 99  545 
LF066 Penicillium sp.  551  Penicillium chrysogenum strain JCM 22826  AB479305.1 99  549 Mar. Drugs 2011, 9  
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Table 1. Cont. 
LF073  Aspergillus sp.  533  Aspergillus versicolor isolate UOA/HCPF 8709  FJ878627.1  100  532 
LF177  Alternaria sp.  568  Lewia infectoria strain IA310  AY154718  99  561 
LF178  Cladosporium sp.  479 
Fungal endophyte sp. g6 
Cladosporium cladosporioides strain CC1 
HM537022.1 
HM210839.1 
100 
100 
479 
479 
LF179  Mycelia sterilia  559 
Fungal endophyte isolate 9137 
Paraphaeosphaeria sp. LF6 
EF419991.1 
GU985234.1 
100 
99 
555 
557 
LF183  Cladosporium sp.  523 
Dothideomycetes sp. 11366 
Cladosporium cladosporioides isolate SLP001 
GQ153254.1 
FJ932747.1 
99 
99 
522 
521 
LF184  Cladosporium sp.  475 
Fungal endophyte sp. g6 
Cladosporium cladosporioides strain CC1 
HM537022.1 
HM210839.1 
100 
100 
475 
475 
LF236  Fusarium sp.  512 
Fusarium sp. CPK3469 
Gibberella intricans strain ATCC MYA-3861 
FJ827615.1 
GU291255.1 
99 
99 
511 
511 
LF237  Fusarium sp.  503 
Fusarium sp. CPK3337 
Fusarium equiseti strain NRRL 36478 
FJ827616.1 
GQ505743.1 
100 
100 
503 
503 
LF238  Fusarium sp.  513 
Fusarium sp. CPK3469 
Fusarium equiseti strain NRRL 36478 
FJ827615.1 
GQ505743.1 
100 
100 
513 
513 
LF239  Fusarium sp.  509 
Fusarium sp. NRRL 45997 
Fusarium equiseti strain NRRL 36478 
GQ505761.1 
GQ505743.1 
99 
99 
503 
503 
LF240  Mycelia sterilia  528 
Lewia sp. B32C 
Lewia infectoria strain IA241 
EF432279.1 
AY154692.1 
99 
99 
525 
525 
LF241  Mycelia sterilia  513 
Botryosphaeria sp. GU071005 
Sphaeropsis sapinea strain CBS109943 
AB472081.1 
DQ458898.1 
100 
100 
512 
512 
LF242  Penicillium sp.  538  Penicillium brevicompactum isolate H66s1  EF634441.1  99  537 
LF243  Penicillium sp.  532  Penicillium virgatum strain IHB F 536  HM461858.1  100  530 
LF244  Cladosporium sp.  516 
Fungal endophyte sp. g2 
Davidiella tassiana strain BLE25 
HM537019.1 
FN868485.1 
99 
99 
516 
516 
LF245  Fusarium sp.  494 
Fusarium sp. CPK3514 
Fusarium equiseti strain NRRL 13402 
FJ840530.1 
GQ505681.1 
100 
100 
494 
494 
LF246  Volutella sp.  548  Volutella ciliata strain BBA 70047  AJ301966.1  99  547 
LF247  Fusarium sp.  520 
Fusarium sp. LD-135 
Fusarium equiseti strain NRRL 13402 
EU336989.1 
GQ505681.1 
99 
99 
509 
504 
LF248  Botrytis sp.  504 
Fungal endophyte sp. g18 
Botryotinia fuckeliana strain OnionBC-1 
HM537028.1 
FJ169667.2 
100 
100 
504 
504 
LF249  Penicillium sp.  552 
Penicillium sp. BM 
Penicillium commune isolate HF1 
GU566211.1 
GU183165.1 
99 
99 
551 
551 
LF250  Penicillium sp.  564  Penicillium chrysogenum strain ACBF 003-2  GQ241341.1  97  547 
LF251  Penicillium sp.  550 
Penicillium sp. F6 
Penicillium chrysogenum strain ACBF 003-2 
GU566250.1 
GQ241341.1 
100 
100 
550 
550 
LF252  Fusarium sp.  513 
Fusarium sp. NRRL 45997 
Fusarium equiseti strain NRRL 36478 
GQ505761.1 
GQ505743.1 
99 
99 
511 
511 
LF253  Trichoderma sp.  543  Hypocrea lixii strain OY3207  FJ571487.1  100  540 
LF254  Clonostachys sp.  525  Bionectria ochroleuca strain G11  GU566253.1  100  524 
LF255  Alternaria sp.  518 
Fungal endophyte sp. g76 
Alternaria alternata strain 786949 
HM537053.1 
GU594741.1 
100 
100 
518 
518 Mar. Drugs 2011, 9  
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Table 1. Cont. 
LF256  Botrytis sp.  535  Beauveria bassiana strain G61  GU566276.1 99  533 
LF257  Cladosporium sp. 495  Davidiella tassiana strain G20  GU566258.1 100  495 
LF258  Phoma sp. nov.  538 
Fungal sp. GFI 146 
Septoria arundinacea isolate BJDC06 
AJ608980.1 
GU361965.1 
93 
91 
470 
460 
LF259  Penicillium sp.  522  Penicillium brevicompactum strain: JCM 22849  AB479306.1 100  522 
LF260  Sphaeropsidales  508  Pyrenochaeta cava isolate olrim63  AY354263.1 100  508 
LF491  Aspergillus sp.  555  Petromyces alliaceus isolate NRRL 4181  EF661556.1  99  555 
LF494  Fusarium sp.  469  Fusarium sp. CB-3  GU932675.1 100  469 
LF496  Mycelia sterilia  531  Verticillium sp. TF17TTW  FJ948142.1  99  529 
LF501  Aspergillus sp.  514  Aspergillus granulosus isolate NRRL 1932  EF652430.1  100  514 
LF508  Not identified  501  Phoma sp. W21  GU045305.1 99  497 
LF509  Fusarium sp.  504  Fusarium sp. CPK3514  FJ840530.1  99  503 
LF510  Fusarium sp.  516  Fusarium sp. FL-2010c isolate UASWS0396  HQ166535.1 99  514 
LF514  Trichoderma sp.  546  Trichoderma sp. TM9  AB369508.1 100  546 
LF526  Eurotium sp.  486 
Eurotium sp. FZ 
Eurotium chevalieri isolate UPM A11 
HQ148160.1 
HM152566.1 
100 
100 
486 
486 
LF530  Alternaria sp.  522  Alternaria sp. 7 HF-2010  HQ380788.1 100  522 
LF534  Penicillium sp.  540  Penicillium roseopurpureum strain E2  GU566239.1 99  536 
LF535  Acremonium sp.  525 
Acremonium sp. FSU2858 
Lecanicillium lecanii strain V56 
AY633563.1 
DQ007047.1 
99 
99 
523 
510 
LF537  Cladosporium sp. 503  Cladosporium cladosporioides strain F12  HQ380766.1 100  503 
LF538  Mucor hiernalis  598  Mucor hiemalis isolate UASWS0442  HQ166553.1 100  598 
LF540  Not identified  578  Hypocrea lixii isolate FZ1302  HQ259308.1 99  575 
LF542  Mycelia sterilia  458 
Peyronellaea glomerata isolate NMG_27 
Phoma pomorum var. pomorum strain CBS 
539.66 
HM776432  
FJ427056.1 
99 
99 
457 
457 
LF543  Alternaria sp.  522  Alternaria citri strain IA265  AY154705.1 100  522 
LF547  Aspergillus sp.  539  Aspergillus minutus isolate NRRL 4876  EF652481.1  98  529 
LF550  Mycelia sterilia  524 
Bartalinia robillardoides CBS:122686 
Ellurema sp. 42-3 
EU552102.1 
AY148442.1 
99 
99 
522 
514 
LF552 
Epicoccum 
nigrum 
506  Epicoccum nigrum strain GrS7  FJ904918.1  99  503 
LF553  Aspergillus sp.  528  Aspergillus sp. Da91  HM991178.1 100  528 
LF554  Aspergillus sp.  525  Aspergillus sp. Da91  HM991178.1 100  525 
LF557  Mycelia sterilia  528 
Fusarium sp. FL-2010f 
Fusarium oxysporum strain TS08-137-1-1 
HQ166539.1 
AB470850.1 
99 
 
522 
 
LF558  Not identified  498  Phoma sp. W21  GU045305.1 100  498 
LF562  Tritirachium sp.  504  Tritirachium sp. F13  EU497949.1  99  498 
LF563  Trichoderma sp.  537  Hypocrea lixii isolate DLEN2008014  HQ149778.1 100  537 
LF576  Clonostachys sp.  504  Bionectria cf. ochroleuca CBS 113336  EU552110.1  99  503 
LF577  Penicillium sp.  538  Penicillium brevicompactum isolate NMG_25  HM776430.1 99  534 
LF580 * 
Scopulariopsis 
brevicaulis 
916  Scopulariopsis brevicaulis strain NCPF 2177  AY083220.1 99  686 
LF581  Fusarium sp.  504  Fusarium sp. NRRL 45996  GQ505760.1 99  502 Mar. Drugs 2011, 9  
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Table 1. Cont. 
LF584  Aspergillus sp.  543  Aspergillus sp. N13  GQ169453.1 99  542 
LF590  Penicillium sp.  522  Penicillium citreonigrum strain Gr155  FJ904848.1  100  522 
LF592  Paecilomyces sp.  544 
Fungal endophyte sp. P1201A 
Paecilomyces lilacinus strain CG 271 
EU977225.1 
EU553303.1 
99 
98 
541 
516 
LF594  Mycelia sterilia  531 
Fusarium sp. FL-2010c 
Fusarium acuminatum strain NRRL 54217 
HQ166535.1 
HM068325.1 
99 
99 
527 
527 
LF596  Penicillium sp.  529 
Penicillium sp. FF24 
Penicillium canescens strain QLF83 
FJ379805.1 
FJ025212.1 
100 
100 
529 
529 
LF607  Penicillium sp.  532 
Penicillium sp. 17-M-1 
Penicillium sclerotiorum strain SK6RN3M 
EU076929.1 
EU807940.1 
99 
99 
523 
520 
LF608  Cladosporium sp.  495 
Fungal sp. mh2981.6 
Cladosporium cladosporioides strain CC1 
GQ996077.1  
HM210839.1 
100 
100 
495 
495 
LF610  Clonostachys sp.  528 
Fungal sp. mh2053.3 
Bionectria ochroleuca isolate Rd0801 
GQ996069.1 
HQ115728.1 
99 
99 
524 
524 
LF626  Mycelia sterilia  588  Trichoderma cerinum isolate C.P.K. 3619  GU111565.1 99  586 
LF627  Aspergillus sp.  509  Aspergillus sp. 4-1  HQ316558.1 100  509 
LF629  Mycelia sterilia  510  Cladosporium cladosporioides strain F12  HQ380766.1 99  509 
LF630  Penicillium sp.  518  Penicillium brevicompactum isolate H66s1  EF634441.1  100  518 
LF631  Epicoccum nigrum 514  Epicoccum nigrum strain AZ-1  DQ981396.1 99  512 
LF634  Aspergillus sp.  581  Aspergillus terreus isolate UOA/HCPF 10213  GQ461911.1 99  579 
LF644  Clonostachys sp  528  Bionectria rossmaniae strain CBS 211.93  AF210665.1  99  521 
LF646  Mycelia sterilia  510  Cladosporium cladosporioides strain F12  HQ380766.1 99  509 
A  = anamorph; T = teleomorph; Alternaria  (A) = Lewia  (T); Aspergillus  (A) = Petromyces (T) and Eurotium  (T);  
Beauveria  (A)  =  Cordyceps  (T);  Botrytis  (A)  =  Botryotinia  (T);  Cladosporium  (A)  =  Davidiella  (T);  
Fusarium  (A)  =  Gibberella  (T);  Clonostachys  (A)  =  Bionectria  (T);  Trichoderma  (A)  =  Hypocrea  (T);  
Phoma = Pleurophoma (synonym); nt = nucleotides; * phylogenetic data to LF580 are derived from the 18S rRNA 
gene sequence.  
First of all, morphological criteria enabled the identification of most of the fungal isolates at the 
genus level (Table 1). However, under the culture conditions applied, 11 strains did not produce spores 
and  were  designed  as  “mycelia  sterilia”.  A  morphological  classification  of  these  strains  was  not 
possible. Despite the formation of spores, another four strains could not be classified on the basis of 
morphological characteristics. 
In order to verify the results of the morphological examination and identify the strains at the species 
level, they were subjected to ITS1-5.8S-ITS2 gene sequence analysis. The results obtained from this 
sequence  analysis  corresponded  well  with  those  from  the  morphological  identification  (Table  1, 
Figure 2) and in addition allowed identification of those strains not identified microscopically. In most 
cases, the sequence data and the phylogenetic relationships allowed the identification at the species 
level. Results from BLAST search are depicted in Table 1. Taking together morphological and genetic 
characteristics, most isolates belong to the Ascomycotina with representatives of the fungal classes 
Dothideomycetes  (24  isolates),  Eurotiomycetes,  (25  isolates),  Sordariomycetes  (30  isolates)  and 
Leotiomycetes  (1  isolate).  Only  a  single  isolate  (strain  LF538)  was  classified  as  belonging  to  
the Mucoromycotina.  Mar. Drugs 2011, 9  
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Figure 2. Phylogenetic consensus tree based on ITS1-5.8S-ITS2 gene sequences calculated 
by Bayesian inference assuming the general time reversible (GTR) model (6 substitution 
rate parameters, gamma-shaped rate variation, proportion of invariable sites). Isolates from 
Tethya  aurantium  obtained  during  this  study  are  printed  in  bold.  Numbers  on  nodes 
indicate Bayesian posterior probability values. nt = nucleotides. 
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Figure 2. Cont. 
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Figure 2. Cont. 
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As shown in the phylogenetic tree (Figure 2), 10 isolates of the Dothideomycetes closely affiliated 
to fungal species of the order Capnodiales (Cladosporium spp. and its teleomorph Davidiella). Within 
the  order  Pleosporales  (13  isolates)  5  isolates  were  closely  related  to  Alternaria  sp.,  including  
Lewia  infectoria  as  teleomorph.  From  the  same  order  we  also  isolated  2  strains  of  the  species 
Epicoccum nigrum and 1 Paraphaeosphaeria strain. Furthermore, 5 isolates of the genus Phoma were 
found,  of  which  one  isolate  (strain  LF258)  shows  only  91%  sequence  similarity  to  
Septoria arundinacea as next relative according to BLAST results (Table 1) and presumably represents 
a new species in the Phoma lineage. The low similarity of this isolate to known sequences is also 
reflected in the position in the phylogenetic tree, clustering distinct from other Phoma species. A single 
isolate  (strain  LF241)  was  assigned  to  Sphaeropsis  sapinea/Botryosphaeria  sp.  within  the  order 
Botryosphaeriales in the class Dothideomycetes. 
All 25 isolates assigned to the class Eurotiomycetes were affiliated to the order Eurotiales and are 
represented  by  14  isolates  closely  affiliating  to  Penicillium  species  (P.  glabrum,  P.  virgatum/ 
P. brevicompactum, P. griseofulvum/P. commune, P. chrysogenum, P. sclerotiorum/P. citreonigrum, 
P.  citreoviride/P.  roseopurpureum,  P.  canescens),  10  representatives  of  the  genus  Aspergillus 
(including  2  of  its  teleomorphs,  Petromyces  alliaceus  and  Eurotium  chevalieri)  and  1  isolate  
of Paecilomyces.  
The 30 isolates affiliated to the class Sordariomycetes were grouped into the orders Hypocreales  
(26 isolates), Microascales (2 isolates) and Xylariales (1 isolate). Within the Hypocreales, one isolate 
each was closely related to Beauveria bassiana (strain LF256), Tritirachium album (strain LF562), 
Verticillium sp. (strain LF496), and Volutella ciliata (strain LF246). The most frequent genera within 
this order were Fusarium (13 isolates), Trichoderma (5 isolates, including Hypocrea teleomorphs) and 
Clonostachys (4 isolates, including teleomorphs of Bionectria). The Microascales were represented by 
two isolates of the genus Scopulariopsis. One of these (strain LF064), morphologically classified as 
Scopulariopsis murina, was distantly related to the next cultured relative (89% according to BLAST 
search) and appears as a sister group to the Scopulariopsis lineage in the phylogenetic tree. The order 
Xylariales was represented by only a single isolate (strain LF550), Bartalinia robillardoides. As the 
only representatives of the order Helotiales within the class Leotiomycetes strain LF248 was closely 
related to Botryotinia fuckeliana. 
The combination of microscopic and genetic analyses has proven to be a reliable method for the 
identification of fungal isolates and results from both approaches corresponded quite well (Table 1, 
Figure 2). The reliable identification of isolates is a fundamental prerequisite in order to characterize 
the producers of marine natural products [3], to determine the occurrence of fungal species in different 
habitats, and to correlate distinct secondary metabolite patterns to fungal species. Therefore, we highly 
recommend that morphological identification of fungal isolates consequently should be verified by 
molecular means and thus raise the number of reliably identified species in public databases.  
A number of investigations, mainly with the aim of finding novel natural products, showed that 
most marine sponges harbor a plethora of cultivable fungi within their tissue [10–15,18]. Despite the 
large number of fungi isolated from sponges, a selective accumulation of specific taxa within sponges 
and a truly marine nature of these fungi is doubted, which is why they are commonly referred to as 
“marine-derived” [27,28]. In fact, it could be shown that the phylogenetic diversity of fungi isolated 
from  different  sponges  varies  [17].  It  has  also  been  stated  that  the  taxa  frequently  isolated  from Mar. Drugs 2011, 9  
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sponges resemble those described from terrestrial habitats [11,16,28]. This is in good accordance with 
our results, showing representatives of Acremonium, Aspergillus, Fusarium, Penicillium, Phoma, and 
Trichoderma to be abundant in Tethya aurantium and with those of Wang (2006) demonstrating that 
they also are widely distributed among different sponges from various locations [29]. Although it 
appears that the marine environment indeed provides various habitats for fungi, this has rarely been 
demonstrated. Nonetheless, due to the accumulation of fungi within sponges a large number of strains 
can be isolated which increases the probability to find representatives of less common taxa which 
might  produce  unprecedented  secondary  metabolites.  For  example,  fungi  belonging  to  the  genera 
Beauveria,  Botryosphaeria,  Epicoccum,  Tritirachium,  and  Paraphaeosphaeria  have  rarely  been 
obtained  from  marine  sponges  [11,18,24]  and,  to  the  best  of  our  knowledge,  we  have  isolated 
Bartalinia sp. and Volutella sp. from a marine sponge for the first time.  
Although evidence is  presented that some bacterial  symbionts  of sponges  are the producers of 
metabolites originally assumed to be produced by the sponge [4], equivalent evidence for fungi is 
lacking. There is actually little evidence for sponge-specific fungal associations and the only reports on 
this matter deals with the above mentioned Koralionastes species and a yeast living in symbiosis with 
the  sponge  Chondrilla  sp.  [30].  In  fact,  most  of  the  studies  had  the  biotechnological  potential  of 
sponge-derived fungi in mind but not the ecological role. Our culture-dependent approach was not 
considered to approach the aspect of specificity of the association with the sponge and molecular-based 
studies would be more suited to identify specifically sponge-associated fungi. 
2.2. Secondary Metabolite Analyses 
With the cultivation-based approach used in this study, we obtained a variety of strains from a 
surprisingly broad range of phylogenetic groups of fungi. A selection of the isolated and identified 
fungi was subjected to analysis of their secondary metabolite profiles. Strains were selected in order to 
represent a wide spectrum of genera, representatives of a variety of different genera, some known to 
include  strains  and  species  known  for  the  production  of  secondary  metabolites  others  from  less 
common taxa. Some of the strains selected according to systematic criteria did not produce detectable 
amounts of secondary metabolites under the applied culture conditions. Unraveling their potential of 
secondary metabolite production will require more intense studies. Those extracts which did contain at 
least one compound in significant amounts were analyzed by HPLC with DAD (UV)- and MS-detection 
and the metabolites which could be identified are listed in Table 2. A high percentage of the substances 
identified this way could be verified by 
1H NMR spectroscopy (see Table 2). The majority of these 
metabolites have been reported from fungi before. Two of our previous reports on metabolites from 
fungi isolated from Tethya aurantium deal with the antiproliferative scopularides A–B [25,26] and the 
sorbifuranones A–C [31]. Mar. Drugs 2011, 9  
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Table 2. Secondary metabolites identified in extracts of fungi isolated from the sponge 
Tethya aurantium. 
Genus  Strain  Compound  Reported from 
a  Bioactivity 
a,b 
Method of 
dereplication 
Alternaria  LF177 
infectopyrone 
Alternaria infectoria, 
Leptosphaeria 
maculans/Phoma lingum 
  UV, MS, NMR 
phomenin A & B 
Phoma tracheiphila, 
Leptosphaeria 
maculans/Phoma lingum, 
Ercolaria funera 
phytotoxin  UV, MS, NMR 
Aspergillus 
LF627 
sterigmatocystin 
Aspergillus versicolor, 
Chaetomium 
mycotoxin [32]  UV, MS 
notoamid D  Aspergillus sp.    UV, MS 
stephacidin A  Aspergillus ochraceus  cytotoxic  UV, MS, NMR 
LF547 
cinereain  Botrytis cinerea 
plant growth regulator, 
phytotoxin 
UV, MS, NMR 
(2′E,4′E,6′E)-6-(1′-
carboxyocta-2′,4′,6′-
trien)-9-hydroxydrim-7-
ene-11,12-olide 
Aspergillus ustus    UV, MS, NMR 
(2′E,4′E,6′E)-6-(1′-
carboxyocta-2′,4′,6′-
trien)-9-hydroxydrim-7-
ene-11-al 
Aspergillus ustus    UV, MS, NMR 
compound A 
hit in Scifinder [33], but 
no publication available 
  UV, MS, NMR 
compound B  no hit in database    UV, MS, NMR 
LF553 
sydonic acid  Aspergillus sydowii  weakly antibacterial [34]  UV, MS, NMR 
hydroxysydonic acid  Aspergillus sydowii    UV, MS 
LF584 
WIN-6 6306  Aspergillus flavipes 
substance P antagonist, 
inhibition of HIV-1 
integrase [35] 
UV, MS 
aspochalasines 
Aspergillus flavipes and 
other Aspergillus sp. 
antibiotic, moderately 
cytotoxic [36] 
UV, MS, NMR 
Aspergillus/ 
Petromyces 
LF491 
isokotanin A–C 
Aspergillus alliaceus and 
Petromyces alliaceus 
moderate antiinsectan 
activities [37] 
UV, MS, NMR 
14-(N,N-Dimethyl-L-
leucinyloxy)paspalinine 
Aspergillus alliaceus 
potassium channel 
antagonist [38] 
UV, MS, NMR 
nominine or a similar 
indoloditerpene 
Aspergillus nomius, 
Aspergillus flavus, 
Petromyces alliaceus 
insecticidal properties  UV, MS, NMR Mar. Drugs 2011, 9  
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Table 2. Cont. 
Phoma  LF258 
monocerin 
Helminthosporium monoceras, 
Fusarium larvarum, 
Dreschlera ravenelii, 
Exserohilum rostratum, 
Readeriella mirabilis 
antifungal, 
insecticidal and 
phytotoxic 
properties 
UV, MS 
intermediate in the  
bio-synthesis of 
monocerin 
Dreschlera ravenelii    UV, MS, NMR 
evernin- or 
isoeverninaldehyde 
Guignardia laricina  weak phytotoxin  UV, MS, NMR 
Epicoccum  LF552 
epicoccamide 
Epicoccum purparescens  
and other Epicoccum sp.,  
Aurelia aurita 
  UV, MS 
orevactaene  Epicoccum nigrum 
binding inhibitor of 
HIV-1 rev protein to 
Rev response 
element (RRE) 
UV, MS 
Eurotium  LF526 
echinulin 
Eurotium repens,  
Aspergillus amstelodami, 
Aspergillus echinulatus, 
Aspergillus glaucus 
experimentally 
hepatic and 
pulmonary effects 
UV, MS 
neoechinulines  Aspergillus amstelodami 
antioxidative 
activity 
UV, MS 
auroglaucines and 
flavoglaucine 
Aspergillus and Eurotium spp. 
mycotoxin, shows 
antineo-plastic 
properties [39] 
UV, MS 
Fusarium 
LF236  equisetin 
Fusarium equiseti and 
Fusarium heterosporum 
antibacterial 
activity, inhi-bition 
of HIV-1 integrase  
UV, MS, NMR 
LF238 
equisetin 
Fusarium equiseti and 
Fusarium heterosporum 
antibacterial 
activity, inhi-bition 
of HIV-1 integrase 
UV, MS, NMR 
fusarins  Fusarium moniliforme  mutagenic [40]  UV, MS 
LF594  enniatine  various Fusarium sp. 
ionophore, 
insecticidal, ACAT 
inhibition, GABA 
receptor binding 
UV, MS 
Paecilomyces  LF592  leucinostatins 
Paecilomyces lilacinus  
and other Paecilomyces sp. 
active against  
Gram-positive 
bacteria and fungi 
UV, MS Mar. Drugs 2011, 9  
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Table 2. Cont. 
Penicillium 
LF066 
compound C  no hit in database    UV, MS, NMR 
meleagrin 
Penicillium 
meleagrinum and 
Penicillium 
chrysogenum 
structurally similar to 
tremorgenic mycotoxins 
UV, MS, NMR 
roquefortin C 
Penicillium roquefortii 
and other  
Penicillium sp. 
neurotoxin  UV, MS, NMR 
sorbifuranones A–C 
Penicillium 
chrysogenum [31] 
  UV, MS, NMR 
2′,3′-dihydrosorbicillin 
Penicillium notatum, 
Verticillium intertextum 
weakly antibacterial [41]  UV, MS 
bisvertonolone 
Penicillium 
chrysogenum, 
Verticillium intertextum, 
Acremonium strictum, 
Trichoderma 
longibrachiatum 
-1,6glucan biosynthesis 
inhibitor, antioxidative, 
inducer of hyphal 
malformation in fungi 
UV, MS
ergochromes 
Aspergillus ochraceus, 
Claviceps purpurea, 
Aspergillus aculeatus, 
Gliocladium sp., 
Penicillium oxalicum, 
Phoma terrestris, 
Pyrenochaeta terrestris 
teratogenic effects  UV, MS 
LF259  mycophenolic acid 
Penicillium 
brevicompactum and 
other Penicillium sp. 
antineoplastig, antiviral 
immunosuppressant 
properties, useful in 
treating psoriasis and 
leishmaniasis,  
UV, MS 
LF590 
citreoviridins 
Penicillium citreoviride, 
Penicillium toxicarium, 
Penicillium 
ochrosalmoneum, 
Aspergillus terreus 
neurotoxic  UV, MS, NMR 
territrem B 
Penicillium sp. and 
Aspergillus terreus 
inhibitor of 
acetylcholinesterase 
UV, MS 
LF607 
sclerotiorin 
Penicillium 
sclerotiorum and 
Penicillium multicolor 
inhibits cholesterin ester 
transfer protein activity 
UV, MS 
sclerotioramine      UV, MS, NMR 
compound D  no hit in database    UV, MS, NMR Mar. Drugs 2011, 9  
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Table 2. Cont. 
Penicillium  LF596 
griseofulvin 
Penicillium griseofulvum 
and other Penicillium sp. 
antifungal, possible 
human carcinogen 
UV, MS, NMR 
tryptoquivalin  Aspergillus clavatus  tremorgenic toxin  UV, MS 
nortryptoquivalin 
Aspergillus clavatus and 
Aspergillus fumigatus 
tremorgenic toxin  UV, MS 
fiscalins A and C  Neosartorya fischeri 
substance P inhibitor, 
neurokinin binding 
inhibitor 
UV, MS, NMR 
Scopulariopsis  LF580  scopularide A and B  Scopulariopsis brevicaulis  antiproliferative [25,26]  UV, MS, NMR 
Clonostachys  LF254 
T-988B  Tilachlidium sp.  cytotoxic  UV, MS, NMR 
bionectin B  Bionectria byssicola  antibacterial (MRSA)  UV, MS, NMR 
verticillin C  Verticillium sp.  antibiotic  UV, MS 
a  According  to  the  Dictionary  of  Natural  Products [42]  if  not  stated  otherwise; 
b  blank  cells  indicate that  no  entry 
concerning bioactivity in the Dictionary of Natural Products was available and no report on bioactivity was found. 
For four compounds, database searches [33,42–43] did not lead to a hit (B, C, D) or no publication 
was  available  (A).  The  structure  elucidations  of  compounds  A  and  B,  metabolites  with  modified 
diketopiperazine  substructures,  and  compound  D,  a  new  azaphilone  derivative,  are  in  progress. 
Compound  C  was  identified  as  the  new  metabolite  cillifuranone  and  its  structure  is  described  in  
the following.  
Penicillium strain LF066, the producer of cillifuranone, was singled out for further investigations, 
because first surveys proved it to be a very potent producer of secondary metabolites. From the same 
strain,  sorbifuranone  B  and  C  as  well  as  2′,3′-dihydrosorbicillin  have  already  been  described  by 
Bringmann et al. [31] and it was obvious that the full potential of the strain had not been exploited, yet. 
Further  analysis  led  to  the  detection  of  xanthocillines  and  sorbifuranones  and  the  isolation  of 
sorbifuranone B, meleagrin, roquefortin C, a couple of ergochromes as well as the new cillifuranone (1) 
whose structure was elucidated based on 1D and 2D NMR experiments. 
The 
13C NMR spectrum of 1 displayed 10 clearly distinguishable carbon signals which was in good 
agreement  with  the  molecular  formula  C10H12O4,  deduced  from  the  result  of  a  HRESI-MS 
measurement (calculated for C10H12O4Na 219.0628, measured 219.0627). The carbon signals included 
resonances  belonging  to  three  carbonyl  or  enol  carbons  (δC  170.9,  196.7  and  201.7),  three  sp
3 
hybridized methylene  carbons (δC 20.9,  31.6 and  76.3), one methyl  group (δC 14.0),  two olefinic 
methines (δC 118.5 and 133.0) and finally one quaternary olefinic carbon (δC 112.6). The structure of 
the  molecule  could  be  delineated  from  1D  (
1H, 
13C  and  DEPT)  and  2D  NMR  (
1H-
13C  HSQC,  
1H-
1H COSY and 
1H-
13C HMBC) spectra. From the 
1H-
1H COSY spectrum two separate spin systems 
could be identified. The first one consisted of the olefinic methine groups CH-9 (δC 133.0, δH 7.32) and 
CH-10  (δC  118.5, δH 6.83), forming an  E-configured double bond as proven by their 
3J coupling 
constant of 16 Hz. The corresponding protons H-9 and H-10 both showed 
1H-
13C HMBC correlations 
to the carboxyl carbon C-11 (δC 170.9) as well as to the quarternary carbons of the furanone ring,  
C-3  (δC  201.7)  to  C-5  (δC  196.7).  C-3  was  the  ketone  carbonyl  group  included  in  the  furanone 
substructure which was in accordance with its chemical shift. C-4 (δC 112.6) and C-5 were also part of 
the  furanone  and formed a  tetrasubstituted  double  bond in  which C-5  was located  adjacent  to  an Mar. Drugs 2011, 9  
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oxygen atom. Compared to an unsubstituted enol, the resonance of C-5 was shifted further downfield 
due to the conjugation of the double bond Δ
4,5 with the carbonyl carbon C-3. Apart from C-9 of the 
double bond Δ
9,10, the carbonyl carbon C-3 and the oxygen atom of the furanone ring, Δ
4,5 was also 
connected  to  C-6  of  the  second  spin  system  consisting  of  the  methylene  groups  CH2-6  (δC  31.6, 
δH 2.76) and CH2-7 (δC 20.9, δH 1.76) as well as the methyl-group CH3-8 (δC 14.0, δH 1.03). Thus, the 
second  spin  system  evidently  was  an  n-propyl-chain.  The  furanone  ring  was  completed  with  the 
methylene group CH2-2 (δC 76.3, δH 4.67). Its 
1H and 
13C shifts proved it to be linked to an oxyen 
atom, the 
1H-
13C HMBC correlations to C-3 and C-5 secured its exact position. Thus, the structure of 
cillifuranone (1) could be unambiguously determined (Figure 3, Table 3). 
Figure  3.  Spin  systems  deduced  from  the 
1H-
1H  COSY  spectrum  (bold)  and  selected  
1H-
13C HBMC correlations (arrows) relevant to the structure elucidation of cillifuranone (1).  
 
Table 3. NMR spectroscopic data of cillifuranone (1) in methanol-d4 (500 MHz). 
Cillifuranone (1) 
Position  δC, mult. δH, (J in Hz) COSY  HMBC 
1         
2  76.3, CH2  4.67, s  6  3, 5, 6, 7 
3  201.7, C       
4  112.6, C       
5  196.7, C       
6  31.6, CH2  2.76, t (7.5)  2, 7  4, 5, 7, 8 
7  20.9, CH2  1.76, sext. (7.5)  6, 8  5, 6, 8 
8  14.0, CH3  1.03, t (7.5)  7  6, 7 
9  133.0, CH  7.32, d (16.0)  10  2, 3, 4, 5, 10, 11 
10  118.5, CH  6.83, d (16.0)  9  3, 4, 5, 9, 11 
11  170.9, C       
Cillifuranone (1)  was  tested  in  a  panel  of  bioassays  evaluating  the  compound  with  respect  to 
cytotoxic, antimicrobial  and enzyme inhibitory  activity. Very low activity was only found against 
Xanthomonas campestris (24% growth inhibition) and Septoria tritici (20% growth inhibition) at a 
concentration of 100 µM. 
Strain LF066 was identified as Penicillium chrysogenum, a species that in our experience often 
produces  metabolites  deriving  from  sorbicillinol  as  a  biosynthetic  precursor  (sorbicillinoids).  The 
detection of bisvertinolone and the sorbifuranones in culture extracts of the fungus was consistent with 
this  experience.  Furanone  substructures  are  abundant  in  natural  products  and  can  be  found  in Mar. Drugs 2011, 9  
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metabolites  from  bacteria,  fungi  and  plants  [42]  and  presumably  are  products  from  different 
biosynthetic  pathways  [44–46].  From  the  genus  Penicillium  a  number  of  furanone  containing 
compounds has been described, including simple small molecules like penicillic acid, but also more 
complex ring structures such as the rotiorinols [47] or rugulovasines [48]. In most cases the furanone 
ring  is  a  furan-2(5H)-one,  whereas  in  cillifuranone  (1)  we  have  a  furan-3(2H)-one.  With  that 
differentiation being made the number of related compounds gets fewer, furan-3(2H)-ones do not seem 
to  be  as  ubiquituous  as  the  furan-2(5H)-ones.  From  Penicillium  strains,  apart  from  the  above 
mentioned sorbifuranones, berkeleyamide D [49] and trachyspic acid [50], both spiro compounds like 
sorbifuranone C, are examples. The new cillifuranone represents a substructure of the sorbifuranones, 
albeit with a different configuration of the exocyclic double bond, and represents the substructure 
which makes the sorbifuranones unique in the compound class of the sorbicillinoids. Just recently 
Bringmann  et  al.  [31]  published  the  structures  of  the  sorbifuranones  and  postulated  1  to  be  an 
intermediate in their biosynthesis (Figure 4) which makes the isolation of 1 a very interesting result. 
The only difference between the postulated intermediate and our structure is, as stated above, the 
configuration of the double bond. However, in the crude extract of the strain, we detected two isomers 
with the same molecular weight and a very similar UV-spectrum, so that we assume that both isomers 
were present, but after the isolation process only the E-isomer was obtained, so that it might be the 
favoured configuration under the applied conditions. 
Figure  4.  Biosynthesis  of  sorbifuranone  A  via  Michael  reaction  of  an  isomer  of 
cillifuranone (1) and sorbicillinol as postulated by Bringmann et al. (modified from [31]). 
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3. Experimental Section 
3.1. Sampling Sites  
The Limsky kanal (Canal di Lemme or Limsky channel) is a semi-closed fjord-like bay in the 
Adriatic Sea nearby Rovinj (Istrian Peninsula, Croatia). It is situated along an east-west axis, with an 
approximate length of 1 km and a maximum width of about 650 m and reaches a maximum depth of 
32 m [51]. The sampling site was located at N45° 7972′ and E13° 43,734′. 
3.2. Sponge Collection 
Several specimens (13) of the Mediterranean sponge Tethya aurantium were collected by scuba 
diving. They were obtained in April 2003, June 2004, May 2005 and August 2006 in a depth of 5–15 m. 
The sponges were collected into sterile plastic bags, cooled on ice and transported immediately to the 
laboratory, where they were washed three times with sterile filtered seawater (0.2 µm). The sponge 
tissue was then cut into small pieces of approximately 0.1 cm
3 each, which were either placed directly 
onto GPY agar plates (LF236 to LF255) or homogenized and diluted with membrane-filtered seawater 
(all other isolates). 
3.3. Isolation, Cultivation and Storage of Fungi 
Fungi were isolated on a low nutrient GPY agar, based on natural seawater of 30 PSU, containing 
0.1% glucose, 0.05% peptone, 0.01% yeast extract and 1.5% agar. Small pieces of sponge tissue or  
50 µL of the homogenate (undiluted or 1:10 or 1:100 diluted with sterile seawater) were used as 
inoculum. The agar plates were incubated for periods of 3 days to 4 weeks and were checked regularly 
for fungal colonies, which were then transferred to GPY agar plates.  Pure cultures were used for 
morphological  identification  by  light  microscopy  and  for  scanning  electron  microscopy.  Fungal 
isolates were stored as agar slant cultures at 5 ° C, and additionally were conserved at −80 °C  using 
Cryobank vials (Mast Diagnostica). 
3.4. Morphological Identification of Fungal Isolates 
The  morphology  of  GPY  agar  grown  fungal  isolates  was  studied  using  a  stereo  microscope  
(10–80×  magnification) and a phase-contrast microscope (300–500×  magnification). By this method, 
the majority of spore-producing isolates could be identified up to the generic level using the tables of 
Barnett and Hunter [52] and, for more detailed descriptions, the site of MycoBank [53]. Morphological 
identification  of  the  selected  pure  cultures  was  supported  by  light  microscopy  and  scanning  
electron microscopy. 
3.5. Scanning Electron Microscopy 
For electron microscopy, young GPY agar colonies were cut in 1 cm
2 samples, transferred through 
an ethanol series (30, 50, 70, 90, 3 ×  100%; each 15 min) and subsequently critical-point-dried in 
liquid carbon dioxide (Balzers CPD030). Samples were sputter-coated with gold-palladium (Balzers 
SCD004) and analyzed with a ZEISS DSM 940 scanning electron microscope. Mar. Drugs 2011, 9  
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3.6. Genetic Identification of Fungal Isolates and Phylogenetic Analysis 
DNA-extraction was performed using the Precellys 24 system (Bertin Technologies). To one vial of 
a Precellys grinding kit with a glass beads matrix (diameter 0.5 mm, peqlab Biotechnologies GmbH) 
400  µL  DNAse-free  water  (Fluka)  were  added.  Cell  material  from  the  fungal  culture  was  then 
transferred  to  this  vial  and  homogenized  two  times  for  45  s  at  a  shaker  frequency  of  6500.  The 
suspension was centrifuged at 6000 g for 10 min and 15 ° C. The supernatant was stored at −20 °C  until 
further use in PCR.  
Fungal  specific  PCR  by  amplifying  the  ITS1-5.8S  rRNA-ITS2  fragment  was  carried  out  using 
puReTaq™ Ready-To-Go™ PCR Beads (GE HEalthcare) with the ITS1 (5′-TCC GTA GGT GAA 
CCT  GCG  G-3′)  and  ITS4  (5′-TCC  TCC  GCT  TAT  TGA  TAT  GC-3′)  primers  according  to  
White et al. [54]. PCR was conducted as follows: initial denaturation (2 min at 94 ° C), 30 cycles of 
primer denaturation (40 s at 94 ° C), annealing (40 s at 55 ° C), and elongation (1 min at 72  ° C) 
followed by a final elongation step (10 min at 72 ° C). PCR products were checked for correct length 
(complete  ITS1,  5.8S  rRNA  and  ITS2  fragment  length  of  Penicillium  brevicompactum  strain  
SCCM 10-I3 (EMBL-acc. No. EU587339 is 494 nucleotides), a 1% agarose gel in 1×  TBE buffer  
(8.9 mM Tris, 8.9 mM borate, 0.2 mM EDTA).  
PCR products were sequenced using the ABI PRISM
® BigDye™ Terminator Ready Reaction Kit 
(Applied Biosystems) on an ABI PRISM
® 310 Genetic Analyzer (Perkin Elmer Applied Biosystems). 
The ITS1 primer was used for sequencing. Sequence data were edited with ChromasPro Version 1.15 
(Technelysium Pty Ltd.). Sequences from fungal strains obtained during this study were submitted to 
the EMBL database and were assigned accession numbers (FR822769-FR822849). Closest relatives 
were identified by sequence comparison with the NCBI Genbank database using BLAST (Basic Local 
Alignment Search Tool) [55]. Sequences were aligned using the ClustalX version 2.0 software [56] 
and  the  alignment  was  refined  manually  using  BioEdit  (version  7.0.9.0)  [57].  For  alignment 
construction, ITS1-5.8S-ITS2 gene fragments from closest cultured relatives according to BLAST as 
well  as  type  strains  were  used,  whenever  possible.  However,  not  from  all  fungal  species,  ITS 
sequences from type strains were available in NCBI/Genbank. The ITS1-5.8S-ITS2 gene sequence of 
Saccharomyces boulardii strain UOA/HCPF EM10049 (acc. No. FJ433878) was used as outgroup 
sequence  for  phylogenetic  calculations.  Phylogenetic  calculations  were  performed  with  all  closest 
relatives according to BLAST results (data not shown). For clarity, not all of these sequences were 
included in Figure 2. Phylogeny was inferred using MrBayes version 3.1 [58,59], assuming the GTR 
(general time reversible) phylogenetic model with 6 substitution rate parameters, a gamma-shaped rate 
variation with a proportion of invariable sites and default priors of the program. 1,000,000 generations 
were  calculated  and  sampled  every  1000th  generation.  Burn-in  frequency  was  set  to  25%  of  the 
samples. The consensus tree was edited in Treeview 1.3 [60]. 
3.7. Fermentation and Production of Extracts 
The  fungi  were  inoculated  in  2  L  Erlenmeyer  flasks  containing  750  mL  modified  
Wickerham-medium  [61],  which  consisted  of  1%  glucose,  0.5%  peptone,  0.3%  yeast  extract,  
0.3% malt extract, 3% sodium chloride (pH = 6.8). After incubation for 11–20 days at 28 °C  in the Mar. Drugs 2011, 9  
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dark as static cultures, extracts of the fungi were obtained. The mycelium was separated from the 
culture medium and extracted with ethanol (150 mL). The fermentation broth was extracted with ethyl 
acetate (400 mL). Both extracts were combined. Alternatively, cells and mycelium were not separated 
and the culture broth was extracted together with the cells of some cultures using ethyl acetate. After 
evaporation of the solvents, the powdery residue was reextracted with ethyl acetate (100 mL). The 
resulting residues were dissolved in 20 mL methanol and subjected to analytical HPLC-DAD-MS. 
3.8. Chemical Analysis 
UV-spectra  of  the  identified  metabolites  were  obtained  on  a  NanoVue  (GE  Healthcare).  NMR 
spectra were recorded on a Bruker DRX500 spectrometer (500 and 125 MHz for 
1H and 
13C NMR, 
respectively), using the signals of the residual solvent protons and the solvent carbons as internal 
references  (δH  3.31  ppm  and  δC  49.0  ppm  for  methanol-d4).  High-resolution  mass  spectra  were 
acquired  on  a  benchtop  time-of-flight  spectrometer  (MicrOTOF,  Bruker  Daltonics)  with  positive 
electrospray ionization. Analytical reversed phase HPLC-DAD-MS experiments were performed using 
a C18 column (Phenomenex Onyx Monolithic C18, 100 ×  3.00 mm) applying an H2O (A)/MeCN (B) 
gradient with 0.1% HCOOH added to both solvents (gradient: 0 min 5% B, 4 min 60% B, 6 min 
100% B;  flow  2  mL/min)  on  a  VWR  Hitachi  Elite  LaChrom  system  coupled  to  an  ESI-ion  trap 
detector (Esquire 4000, Bruker Daltonics). 
Preparative HPLC was carried out using a VWR system consisting of a P110 pump, a P311 UV 
detector, a smartline 3900 autosampler and a Phenomenex Gemini-NX C18 110A, 100 ×  50 mm, 
column or a Merck Hitachi system consisting of an L-7150 pump, an L-2200 autosampler and an  
L-2450 diode array detector and a Phenomenex Gemini C18 110A AXIA, 100 ×  21.20 mm, column. 
For the preparation of cillifuranone (1), the same solvents were used as for the analytical HPLC, 
with a gradient from 10% B, increasing to 60% B in 17 min, to 100% B from 17 to 22 min. 1 eluted 
with a retention time of 6.8 min and the amount of 23.2 mg of 1 could be obtained from a culture 
volume of 10 L. 
Properties of cillifuranone (1): pale yellow needles; UV (MeOH) λmax (logε) 278 (4.36); for 1D and 
2D NMR data see Table 3 and SI; HRESIMS m/z 219.0627 (calcd for C10H12O4Na 219.0628). 
3.9. Bioassays 
Possible  antimicrobial  effects  of  cillifuranone  (100  µM)  were  tested  against  Bacillus  subtilis  
(DSM  347),  Brevibacterium  epidermidis  (DSM  20660),  Dermabacter  hominis  (DSM  7083),  
Erwinia  amylovora  (DSM  50901),  Escherichia  coli  K12  (DSM  498),  Pseudomonas  fluorescens 
(NCIMB 10586), Propionibacterium acnes (DSM 1897
T), Pseudomonas aeruginosa (DSM 50071), 
Pseudomonas  syringae  pv.  aptata  (DSM  50252),  Staphylococcus  epidermidis  (DSM  20044), 
Staphylococcus  lentus  (DSM  6672),  Xanthomonas  campestris  (DSM  2405),  Candida  albicans  
(DSM  1386),  Phytophthora  infestans,  and  Septoria  tritici  according  to  Schneemann  et  al.  [62].  
In addition, cytotoxic activity of cillifuranone (50 µM) towards the human hepatocellular carcinoma 
cell line HepG2 and the human colon adenocarcinom cell line HT29 were performed according to  
Schneemann  et  al.  [62].  Inhibitory  activities  of  cillifuranone  (10  µM)  against  the  enzymes Mar. Drugs 2011, 9  
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acetylcholinesterase,  phosphodiesterase  (PDE-4B2),  glycogen  synthase  kinase  3β,  protein  tyrosin 
phosphatase 1B, and HIV-1 reverse transcriptase were tested according to Helaly et al. [63]. 
4. Conclusion 
The  marine  sponge  T.  aurantium  was  found  to  be  a  valuable  source  of  secondary  metabolite 
producing fungi. In addition to a variety of known substances, several new natural products were found 
and it is likely that additional ones can be identified during further studies. The antiproliferative active 
scopularides  [25,26]  were  the  first  new  metabolites  from  a  Scopulariopsis  species  isolated  from  
T. aurantium. The new cillifuranone (1) is a second example of a natural product produced by a fungal 
isolate from T. aurantium. Additional compounds were detected of which the chemical structures are 
not yet described. The application of alternative cultivation methods, which have not been used so far, 
are  expected  to  further  increase  the  spectrum  of  produced  metabolites  of  our  isolates  obtained  
from T. aurantium. 
The  combination  of  morphological  criteria  and  the  results  of  the  ITS1-5.8S-ITS2  fragment 
sequencing have been proven to be a valuable tool for the identification of fungal isolates. Apart from 
representatives  of  genera,  which  are  widely  distributed  in  terrestrial  samples  and  in  addition  also 
reported  from  different  sponges,  we  also  identified  members  of  taxa  which  so  far  have  not  been 
described  to  be  associated  with  sponges.  These  strains  distantly  affiliated  to  Bartalinia  sp.  and 
Votutella sp. and one strain most likely is a new Phoma species.  
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